These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14703356)

  • 1. Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases.
    Xie J; Comeau AB; Seto CT
    Org Lett; 2004 Jan; 6(1):83-6. PubMed ID: 14703356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel synthesis of a library of bidentate protein tyrosine phosphatase inhibitors based on the alpha-ketoacid motif.
    Chen YT; Seto CT
    Bioorg Med Chem; 2004 Jun; 12(12):3289-98. PubMed ID: 15158797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
    Xie J; Seto CT
    Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
    Bialy L; Waldmann H
    Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
    Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis of tyrosine phosphatase inhibitor selectivity for the virulence factors YopH and SptP.
    Hu X; Vujanac M; Stebbins CE
    J Mol Graph Model; 2004 Oct; 23(2):175-87. PubMed ID: 15363459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
    Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
    Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidic alpha-ketocarboxylic acids and sulfonamides as inhibitors of protein tyrosine phosphatases.
    Chen YT; Xie J; Seto CT
    J Org Chem; 2003 May; 68(10):4123-5. PubMed ID: 12737607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans-Beta-nitrostyrene derivatives as slow-binding inhibitors of protein tyrosine phosphatases.
    Park J; Pei D
    Biochemistry; 2004 Nov; 43(47):15014-21. PubMed ID: 15554709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity phosphatases as targets for antineoplastic agents.
    Lyon MA; Ducruet AP; Wipf P; Lazo JS
    Nat Rev Drug Discov; 2002 Dec; 1(12):961-76. PubMed ID: 12461518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies.
    Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H
    Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of phosphatase inhibitors.
    Vintonyak VV; Antonchick AP; Rauh D; Waldmann H
    Curr Opin Chem Biol; 2009 Jun; 13(3):272-83. PubMed ID: 19410499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.
    Barr AJ
    Future Med Chem; 2010 Oct; 2(10):1563-76. PubMed ID: 21426149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the subsite preferences of protein tyrosine phosphatase PTP-1B using combinatorial chemistry approaches.
    Pellegrini MC; Liang H; Mandiyan S; Wang K; Yuryev A; Vlattas I; Sytwu T; Li YC; Wennogle LP
    Biochemistry; 1998 Nov; 37(45):15598-606. PubMed ID: 9843364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-assisted discovery of Variola major H1 phosphatase inhibitors.
    Phan J; Tropea JE; Waugh DS
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):698-704. PubMed ID: 17505108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking and 3D-QSAR studies of Yersinia protein tyrosine phosphatase YopH inhibitors.
    Hu X; Stebbins CE
    Bioorg Med Chem; 2005 Feb; 13(4):1101-9. PubMed ID: 15670918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the inhibitory potential of five squaric acid derivatives against pancreatic lipase.
    Bobcheva Z; Zhiryakova D; Guncheva M
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):587-91. PubMed ID: 21438711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Yersinia protein tyrosine phosphatase by phosphonate derivatives of calixarenes.
    Vovk AI; Kononets LA; Tanchuk VY; Cherenok SO; Drapailo AB; Kalchenko VI; Kukhar VP
    Bioorg Med Chem Lett; 2010 Jan; 20(2):483-7. PubMed ID: 20015646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.